Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center's Experience With 400 Patients

OBJECTIVE: Patients with rheumatoid arthritis (RA) and other systemic rheumatic diseases (SRDs) are at increased risk of developing herpes zoster (HZ). Zoster recombinant adjuvanted (ZRA) is a recombinant vaccine approved by the Food and Drug Administration in 2018. Concern has been raised that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Emma, Weinblatt, Michael E., Massarotti, Elena, Griffin, Frances, Emani, Srinivas, Desai, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301873/
https://www.ncbi.nlm.nih.gov/pubmed/32412669
http://dx.doi.org/10.1002/acr2.11150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301873/
https://www.ncbi.nlm.nih.gov/pubmed/32412669
http://dx.doi.org/10.1002/acr2.11150

Ejemplares similares